Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports

British Medical Journal

Volumn 318, Issue 7201, 1999, Pages 16-19

  Williamson, L M ^a   Lowe, S ^a   Love, E M ^a   Cohen, H ^b,c   Soldan, K ^c   McClelland, D B L ^c   Skacel, P ^c   Barbara, J A J ^c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c London Hospitals ^*

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; CRYOGLOBULIN;

ARTICLE; BACTERIAL INFECTION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HUMAN; IRELAND; LUNG INJURY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PURPURA; THROMBOCYTE TRANSFUSION; UNITED KINGDOM; VIRUS INFECTION; BLOOD COMPONENT THERAPY; BLOOD GROUP INCOMPATIBILITY; HEALTH SURVEY; MEDICAL ERROR; MORTALITY; PLASMA; RISK MANAGEMENT; STATISTICS;

BLOOD COMPONENT TRANSFUSION; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CRYOGLOBULINS; ERYTHROCYTE TRANSFUSION; GREAT BRITAIN; HUMANS; IRELAND; MEDICAL ERRORS; PLASMA; PLATELET TRANSFUSION; POPULATION SURVEILLANCE; RISK MANAGEMENT;

EID: 0033519809     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7201.16     Document Type: Article

References (17)

1. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
2. McClelland DBL, Phillips P. Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ 1994;308:1205-6.
3. Williamson LM, Heptonstall J, Soldan K. A SHOT in the arm for safer blood transfusion. BMJ 1996;313:1221-2.
4. BCSH Blood Transfusion Task Force. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine 1996;6:273-83.
5. Shiba MK, Tadokoron K, Sawanobori M, Nakajima K, Suzuki K, Juji T. Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received the filtered platelets. Transfusion 1997;37:457-62.
6. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DBL, et al. SHOT annual report 1996-1997. Manchester: SHOT Office, Manchester Blood Centre, 1998.
7. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DBL, et al. SHOT annual report 1997-1998. Manchester: SHOT Office, Manchester Blood Centre, 1999.
8. NHS Executive. Better blood transfusion. London: NHS Executive, 1999. (Circular HSC 1998/99.)
9. Centre National d'Hémovigilance. L'hémovigilance actualites et dossiers: lettre d'information de l'Agence Française du sang en collaboration avec le Centre National d'Hémovigilance. Avril 1995 and Mars 1996. Paris: Agence Française du Sang, 1999.
10. Kaplan HS, Battles JB, Van der Schaaf TW, Shea CE, Mercer SQ. Identification and classification of the causes of events in transfusion medicine. Transfusion 1998;38:1071-81.
11. Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen-labelling policy decreases the incidence of erroneous blood grouping of blood bank specimens. Transfusion 1997;37:1169-72.
12. Ingrand P, Surer-Pierres N, Houssay D, Salmi LR. Reliability of the pretransfusion bedside compatibility test: association with transfusion practice and training. Transfusion 1998;98:1030-6.
13. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
14. Blajchman MA, Ali AM, Richardson HL. Bacterial contamination of cellular blood components. Vox Sang 1994;67:25-34.
15. Calman KC. Cancer: science and society and the communication of risk. BMJ 1996;313:799-802.
16. AuBuchon JP, Kruskall MS. Transfusion safety; realigning efforts with risks. Transfusion 1997;37:1211-6.
17. McClelland DBL. Treating a sick process. Transfusion 1998;38:999-1103.